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Prevalence of insomnia symptoms and
their associated factors in patients treated
in outpatient clinics of four general
hospitals in Guangzhou, China
Wei Zheng1, Xin-Ni Luo1, Hai-Yan Li1, Xiao-Yin Ke1, Qing Dai1, Chan-Juan Zhang1, Chee H. Ng2, Gabor S. Ungvari3,4,
Yu-Tao Xiang5* and Yu-Ping Ning1*

Abstract
Background: Data on the prevalence of insomnia symptoms in medical outpatient clinics in China are lacking. This
study examined the prevalence of insomnia symptoms and their socio-demographic correlates in patients treated
at medical outpatient clinics affiliated with four general hospitals in Guangzhou, a large metropolis in southern
China.
Method: A total of 4399 patients were consecutively invited to participate in the study. Data on insomnia and its
socio-demographic correlates were collected with standardized questionnaires.
Results: The prevalence of any type of insomnia symptoms was 22.1% (95% confidence interval (CI): 20.9–23.3%);
the prevalence of difficulty initiating sleep was 14.3%, difficulty maintaining sleep was 16.2%, and early morning
awakening was 12.4%. Only 17.5% of the patients suffering from insomnia received sleeping pills. Multiple logistic
regression analysis revealed that male gender, education level, rural residence, and being unemployed or retired
were negatively associated with insomnia symptoms, while lacking health insurance, older age and more severe
depressive symptoms were positively associated with insomnia symptoms.
Conclusions: Insomnia symptoms are common in patients attending medical outpatient clinics in Guangzhou.
Increasing awareness of sleep hygiene measures, regular screening and psychosocial and pharmacological
interventions for insomnia are needed in China.
Trial registration: ChiCTR-INR-16008066. Registered 8 March 2016.
Keywords: Insomnia symptoms-medical outpatients-China

Background
Insomnia symptoms, including difficulty initiating sleep
(DIS), difficulty maintaining sleep (DMS) and early
morning awakening (EMA), are major health problems
worldwide [1–4]. Insomnia is associated with daytime fatigue, reduced activity, absenteeism, poor quality of life
(QOL), and significant medical and societal costs [5, 6].
* Correspondence: xyutly@gmail.com; ningjeny@126.com
5
Unit of Psychiatry, Faculty of Health Sciences, University of Macau, Macao
SAR, China
1
The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou
Huiai Hospital), Guangzhou, China
Full list of author information is available at the end of the article

The prevalence of sleep problems in the general population ranges from 6 to 76.3% across various countries
using different time-frame, measurements and sampling
methods [7–10]. Commonly reported contributing factors to insomnia symptoms include advanced age, female
gender, low personal income and educational level, and
psychiatric or somatic conditions [9, 11, 12].
In order to develop preventive strategies and allocate
health resources, it is important to examine the prevalence
of insomnia symptoms. In Western countries the prevalence of insomnia symptoms has been extensively examined
in both the general population [13] and medical conditions,
such as epilepsy [14] and stroke [15]. Sociocultural and
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economic factors play an important role in determining the
duration and quality of sleep [16, 17]. Therefore, characteristics of insomnia symptoms need to be examined in ethnically and socio-culturally diverse populations. In China,
patterns of insomnia symptoms in the general population
have been well-documented. A recent meta-analysis of 17
studies found that the pooled prevalence of insomnia symptoms in the Chinese general population was 15.0% [1].
Patients treated in medical outpatient clinics usually
have insomnia symptoms resulting in poor sleep quality
[18]. A cohort study from 1999 to 2010 found there was
a significant increase in prevalence of sleep problems in
hospital outpatients [19]. The prevalence of insomnia
symptoms in outpatient clinics has been mixed across
studies [12, 20]. For example, the prevalence of insomnia
symptoms was 11.7% in Japanese (n = 6277) general hospital outpatients [12] while the corresponding figure was
38.5% in China [20].
Data on insomnia symptoms in patients attending
medical outpatient clinics their related risk factors are
lacking in China. This study aimed to determine the
one-month prevalence of different types of insomnia
symptoms in Chinese outpatients treated in clinics attached to general hospitals, and also explore their associations with demographic characteristics. In China, there
are very few outpatient clinics located in the community;
most clinically stable patients with medical conditions
attend outpatient clinics attached to general hospitals.
In China, according to the size and specialization of
clinical care and research, hospitals are classified into
the following three levels [21]: 1. Level-I hospitals are
small, community hospitals that only provide basic medical care; 2. Level-II hospitals are regional medical centres that deliver complex health care to patients with
severe medical and psychiatric conditions; 3. Level-III
hospitals have the highest staff-patient ratio and usually
the best medical resources.

Methods
Study sites and participants

This was a multi-center, cross-sectional survey conducted in Guanzhou, a large metropolis in southern
China, between March 15, 2016 and June 30, 2016. Patients treated in the neurological, cardiovascular, gastrointestinal, and gynecological outpatient clinics attached
to four major level-III hospitals (see Additional file 1) in
Guangzhou (the First Affiliated Hospital of Guangzhou
University of Traditional Chinese Medicine, Guangzhou
Panyu Central Hospital, Nanfang Hospital affiliated with
Southern Medical University, and the Third Affiliated
Hospital of Sun Yet-Sen University) were consecutively
invited to participate in the study if they fulfilled the following inclusion criteria: (1) age of 18 years or above; (2)
ability to communicate in Chinese (Mandarin or
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Cantonese) and (3) understand the purpose and content
of the survey.
The study protocol was approved by the Ethics Committee of the Affiliated Brain Hospital of Guangzhou Medical
University. Written informed consent was obtained from
each patient.
Assessments and evaluation

Information on basic socio-demographic characteristics
was collected with a questionnaire by trained psychiatrists and PhD students in clinical psychology at the outpatient clinics of the participating hospitals. All
investigators attended a training that introduced the
study objectives, procedures of the data collection, and
ethical issues of the survey.
Information of three basic types of insomnia symptoms occurring in the past month was ascertained by
asking three standard questions, that had been used in
previous studies [2, 22]: DIS: Did you ever have difficulties in falling sleep?; DMS: ‘Did you ever have difficulties
in maintaining sleep?’; and EMA: ‘Did you ever wake up
in the middle of the night or early morning and have difficulties in falling asleep again?’. There were three options to reply to these questions: ‘No’, ‘Sometimes’ and
‘Often’. If patients answered “often” to any of the three
questions, they were classified into the “suffering from
any insomnia symptoms” group.
The presence and severity of depressive symptoms
were assessed with the validated Chinese version of the
Patient Health Questionnaire 9 (PHQ-9) [23, 24], which
has nine items; each was rated from 0 to 3. Higher
scores indicated more severe depressive symptoms. The
PHQ-9 score of 10 was used as a cut-off for “having depressive symptoms”, which has satisfactory sensitivity
(0.77) and specificity (0.76) in Chinese medical outpatients [23]. Anxiety symptoms were evaluated with
the validated Chinese version of the 7-item Generalized Anxiety Disorder (GAD-7) [25, 26]. Each item of
the GAD-7 was rated from 0 to 3. Higher scores indicated more severe anxiety symptoms. Patients with a
GAD-7 total score of 10 was considered as “having
anxiety symptoms”; this cut-off point that has good
sensitivity (86.2%) and specificity (95.5%) in Chinese
population [25].
Statistical analysis

All data were analyzed using the SPSS, Version 20.0 statistical software (SPSS Inc., Chicago, United States). The
comparison between patients with and without insomnia
symptoms with regard to demographic characteristics
was conducted by chi-square tests, two independent
samples t-tests or Mann-Whitney U test, as appropriate.
Multiple logistic regression analysis with the “Enter”
method was performed to determine the independent
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were 39.6, 27.3, and 33.1%, respectively. Only 17.5% patients (170/973) with insomnia symptoms were taking
any type of “sleeping pills (sedatives and hypnotics)”.
Table 1 shows the comparison between patients with
and without insomnia symptoms with respect to demographic characteristics. Patients with insomnia symptoms were more likely to be females, older in age, had
lower personal income, lower education level, family history of psychiatric disorders, and more severe anxiety
and depressive symptoms. Significant differences were
also found between the two groups regarding marital
and employment status.
In China, the age of ≥50 years has often been used as
the cutoff value for “older adults” [27, 28]. Following
other studies [27–29], the prevalence figures of various
types of insomnia symptoms by gender and age groups
are listed in Table 2. DIS (14.9% vs. 12.9%), DMS (17.1%
vs. 14.4%), and EMA (12.9% vs. 11.2%) were more frequent in females than in males. Compared to younger
patients (< 50 years), older patients (>/=50 years) reported more frequent DIS (17.0% vs. 13.1%), DMS
(19.8% vs. 14.7%), and EMA (17.2% vs. 10.4%).

relationships between insomnia symptoms and
socio-demographic variables. Each type of insomnia symptoms was separately entered as the dependent variable,
while given the large sample size, all socio-demographic
and clinical characteristics were the independent variables.
The level of significance was set at 0.05 (two-tailed). As
this was an exploratory study, the significance level was
not corrected.

Results
A total of 5284 patients were invited to participate in
the survey of whom 4399 completed all the questionnaires yielding a participation rate of 83.3%. The prevalence of any type of insomnia symptoms was 22.1% (95%
confidence interval (CI): 20.9–23.3%). The weighted
prevalence of any type of insomnia symptoms according
to the distribution of patients in the participating hospitals was 21.0% (95% CI: 20.3–21.6%). In the whole sample, the prevalence of DIS, DMS and EMA was 14.3,
16.2 and 12.4%, respectively. Of the 973 patients who reported insomnia symptoms, the percentage of patients
with one, two, and three types of insomnia symptoms

Table 1 Demographic and clinical characteristics of the study sample

Male gender

Total sample
(n = 4399)

Insomnia symptoms
(n = 973)

Without insomnia symptoms
(n = 3426)

Statistics

N

%

N

%

N

%

χ2

1503

34.2

302

31.0

1201

35.1

Marital status

df

p

5.4

1

0.02

36.9

2

< 0.001

2.9

1

0.09

16.4

2

< 0.001

Single

728

16.5

147

15.1

581

17.0

Married

3528

80.2

765

78.6

2763

80.6

Divorced/widowed

143

3.3

61

6.3

82

2.4

2631

59.8

559

57.5

2072

60.5

Employed

2900

65.9

589

60.5

2311

67.5

Unemployed

800

18.2

201

20.7

599

17.5

Retired

699

15.9

183

18.8

516

15.1

Living alone

415

9.4

99

10.2

316

9.2

0.8

1

0.3

Personal monthly income
>/=6000 (Yuan)

951

21.6

178

18.3

773

22.6

8.1

1

0.004

Rural residence
Employment status

No health insurance

2825

64.2

645

66.3

2180

63.6

2.3

1

0.1

Family history of psychiatric disorders

217

4.9

87

8.9

130

3.8

42.8

1

< 0.001

Current drinking

959

21.8

214

22.0

745

21.7

0.03

1

0.8

Current smoking

594

13.5

136

14.0

458

13.4

0.2

1

0.6

Mean

SD

Mean

SD

Mean

SD

T/Z

df

p

Age (years)

41.8

15.9

44.4

16.1

41.0

15.8

−5.9

4397

< 0.001

Education (years)

10.3

4.2

9.6

4.2

10.5

4.2

5.8

4397

< 0.001

GAD-7 total

3.2

4.2

5.3

5.4

2.6

3.6

−15.9

—a

< 0.001

PHQ-9 total

3.6

4.3

6.5

5.5

2.8

3.5

−22.8

—a

< 0.001

=Mann-Whitney U test; Bolded values are p < 0.05; GAD-7 = Generalized Anxiety Disorder Scale-7; PHQ-9 = Patient Health Questionnaire-9; SF-12 = Medical
Outcomes Study Short Form 12
a

13.4
(10.5–16.3)

19.6
(16.8–22.5)

14.9
(13.7–16.3)

>/=50
(n = 218)

Total

14.3
(13.2–15.3)

17.0
(15.0–19.1)

13.1
(12.0–14.3)

Total %
(95% CI)

Total

>/=50
(n = 253)

< 50
(n = 458)

Age
(years)
(n = 711)

17.1
(15.7–18.5)

22.0
(19.1–25.0)

15.4
(13.9–16.9)

Female %
(95% CI)

14.4
(12.6–16.1)

16.6
(13.4–19.8)

13.1
(11.0–15.3)

Male%
(95% CI)

DMS (n = 711)

16.2
(15.1–17.3)

19.8
(17.6–22.0)

14.7
(13.4–15.9)

Total %
(95% CI)

Total

>/=50
(n = 220)

< 50
(n = 324)

Age
(years)
(n = 544)

CI = confidence interval; DIS = difficulty initiating sleep; DMS = difficulty maintaining sleep; EMA = early morning awakening

12.9
(11.2–14.6)

12.6
(10.5–14.7)

Male %
(95% CI)

13.4
(11.9–14.8)

Female %
(95% CI)

DIS (n = 628)

< 50
(n = 410)

Age
(years)
(n = 628)

Table 2 Prevalence of any type of insomnia symptoms by age and sex

12.9
(11.8–14.2)

19.5
(16.6–22.3)

10.7
(9.4–12.0)

Female%
(95% CI)

11.2
(9.6–12.8)

13.9
(11.0–16.9)

9.6
(7.8–11.5)

Male%
(95% CI)

EMA (n = 544)

12.4
(11.4–13.3)

17.2
(15.1–19.3)

10.4
(9.3–11.5)

Total %
(95% CI)

Total

>/=50
(n = 220)

< 50
(n = 324)

Age
(years)
(n =
4399)

23.2
(21.6–24.7)

30.1
(26.8–33.4)

20.8
(19.1–22.5)

Female%
(95% CI)

20.1
(18.1–22.1)

22.6
(19.0–26.1)

18.7
(16.3–21.2)

Male%
(95% CI)

22.1
(20.9–23.3)

27.0
(24.5–29.4)

20.1
(18.7–21.5)

Total %
(95% CI)

Any insomnia symptoms (n = 4399)
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Table 3 shows the factors that are independently associated with each type of insomnia symptoms. Male gender,
education level, rural residence, and being unemployed or
retired were negatively associated with one or more types
of insomnia symptoms. Lacking health insurance, older
age and more severe depressive symptoms were positively
associated with one or more types of insomnia symptoms.

Discussion
This was the first study that examined the prevalence of
insomnia symptoms and their association with demographic correlates in Chinese patients attending medical
outpatients clinics attached to general hospitals. The
prevalence of any type of insomnia symptoms was
22.1%, which is higher than the figure (15.0%) reported
in a meta-analysis of 17 general population studies in
China [1]. Medical conditions are recognized independent contributors to insomnia [9, 30]. Neurological, cardiovascular, gastrointestinal, and gynecological diseases
result in limited physical or outdoor activity, exposure to
bright light, and increased daytime sleep, all of which
could lead to night-time insomnia symptoms. The prevalence of insomnia symptoms in this study is significantly
higher than the figure (11.7%) in Japanese outpatients

[12]. Differences across studies could be partly due to inconsistencies in the definitions of insomnia symptoms,
time frame (e.g., current, past month, past year or lifetime prevalence), as well as types of physical diseases
and sampling methods. Therefore, comparisons of findings across studies should be made with caution.
Only 17.5% of patients with insomnia symptoms in this
study reported to taking sleeping pills, which is higher
than Chinese nurses (11.7%) [31] and the Chinese general
population (5.4%) [9]. The relatively low treatment rate
may be attributed to the lack of access to treatment and
the reluctance in seeking help among in Chinese people
since they generally do not regard insomnia as a medical
condition [9, 32].
An independent association between depressive symptoms and insomnia symptoms were found in this study,
which is consistent with earlier findings in both Asian
[9, 12, 33] and Western settings [7, 30, 34]. However, the
causality between depressive and insomnia symptoms
could not been identified due to the cross-sectional
study design and the fact that poor sleep is a core feature of depressive disorder [35]. As expected, advanced
age and lack of health insurance were positively associated with insomnia symptoms.

Table 3 Adjusted odds ratios and 95% confidence intervals of sociodemographic characteristics associated with any type of
insomnia symptoms
DIS

DMS

EMA

p

OR

95%CI

p

OR

95%CI

p

OR

95%CI

0.04

0.78

0.61–0.99

0.04

0.79

0.64–0.99

0.20

0.85

0.67–1.09

Single

–

1.0

–

–

1.0

–

–

1.0

–

Married

0.17

0.80

0.59–1.09

0.92

1.02

0.75–1.37

0.42

1.16

0.81–1.66

Divorced/widowed

0.35

1.27

0.76–2.13

0.15

1.44

0.87–2.38

0.24

1.39

0.80–2.42

< 0.001

0.72

0.58–0.89

< 0.001

0.69

0.57–0.85

< 0.001

0.72

0.58–0.90

Employed

–

1.0

–

–

1.0

–

–

1.0

–

Unemployed

0.62

0.94

0.72–1.21

0.04

0.77

0.60–0.99

0.31

0.87

0.66–1.14

Male gender
Marital status

Rural residence
Employment status

Retired

0.71

0.94

0.66–1.32

0.03

0.70

0.51–0.97

0.37

0.85

0.60–1.21

Living alone

0.61

1.09

0.79–1.51

0.42

1.14

0.83–1.56

0.24

1.24

0.87–1.77

Personal monthly income >/= 6000 (Yuan)

0.62

0.94

0.72–1.22

0.12

0.82

0.64–1.06

0.14

0.81

0.61–1.07

No health insurance

< 0.001

1.43

1.15–1.78

0.52

1.07

0.88–1.30

0.46

1.09

0.87–1.36

Family history of psychiatric disorders

0.09

1.39

0.96–2.01

0.12

1.33

0.92–1.91

0.15

1.33

0.90–1.97

Current drinking

0.07

1.24

0.98–1.58

0.83

1.03

0.81–1.29

0.55

0.92

0.71–1.20

Current smoking

0.13

1.26

0.93–1.71

0.64

1.07

0.80–1.44

0.99

1.0004

0.72–1.40

Age (years)

< 0.001

1.02

1.01–1.03

< 0.001

1.03

1.02–1.03

< 0.001

1.03

1.02–1.04

Education (years)

< 0.001

0.95

0.92–0.97

< 0.001

0.96

0.94–0.99

< 0.001

0.96

0.93–0.99

GAD-7 total

0.29

1.02

0.99–1.04

0.49

1.01

0.98–1.04

0.61

1.01

0.98–1.04

PHQ-9 total

< 0.001

1.19

1.15–1.22

< 0.001

1.19

1.16–1.23

< 0.001

1.18

1.15–1.22

Bolded values: p < 0.05; CI = confidence interval; DIS = difficulty initiating sleep; DMS = difficulty maintaining sleep; EMA = early morning awakening; GAD-7 =
Generalized Anxiety Disorder Scale-7; OR = odds ratio; PHQ-9 = Patient Health Questionnaire-9
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This study also confirmed prior findings [36, 37] that
people who lived in rural settings had less insomnia symptoms than their urban counterparts. In urban areas noise
pollution, leisure activities at night, and shift work are frequently unavoidable [37]; in contrast, rural residents are
more likely to have frequent outdoor activities and exposure to natural daylight, which could improve sleep quality
[38]. Consistent with the earlier findings in general population [9, 39], this study found that insomnia symptoms
were associated with lower education level. Persons with
lower education level often face greater work-related
stress, which may lead to insomnia symptoms. This study
did not confirm previous findings that low income [40]
was associated with insomnia symptoms.
The results of this study should be treated with caution due to several methodological shortcomings. First,
due to logistical reasons, this study was only conducted
in outpatient clinics attached to four general hospitals in
Guangzhou, therefore, the findings could not be generalized to all patients in the participating hospitals. Second,
due to the cross-sectional design, the causality between
insomnia symptoms and other variables could not be explored. Third, the sample was heterogeneous in terms of
the primary diagnoses and the severity of medical conditions, which could not be controlled for. Fourth, certain
measures, such as the presence and frequency of insomnia symptoms, were self-reported, which could be subject to recall bias. Fifth, reasons for outpatient visits
were not recorded. In addition, primary sleep disorders
other than insomnia symptoms were not examined. Finally, several variables related to insomnia symptoms,
such as the presence and severity of medical conditions
and primary sleep disorders, sleep quality and the level
of sleep hygiene, frequency of nocturnal micturition, use
of psychotropic medications, work schedule (such as
shifting work), were not collected or evaluated. The
strengths of this study include the large sample size and
the standardized method of data collection.

Conclusion
Insomnia symptoms are common in Chinese patients attending medical outpatient clinics attached to general hospitals. In particular, older age, female gender, urban
residency, employment, lower education level, lack of
health insurance, and more severe depressive symptoms
appear to increase the risk of insomnia symptoms. Regular
screening for insomnia symptoms should be a routine part
of care in Chinese outpatient clinics. Sleep hygiene,
pharmacotherapy and psychosocial interventions for insomnia symptoms should be given more attention in
China. Further surveys are warranted to examine the situation in other parts of China. Longitudinal studies are also
needed to determine the demographic and clinical predictors of insomnia symptoms.

Page 6 of 7

Additional file
Additional file 1: The number of patients from the four outpatient
clinics. (DOCX 31 kb)
Abbreviations
CI: Confidence interval; DIS: Difficulty initiating sleep; DMS: Difficulty
maintaining sleep; EMA: Early morning awakening; GAD-7: Generalized
Anxiety Disorder 7 items; PHQ-9: Patient Health Questionnaire 9;
QOL: Quality of life
Acknowledgements
The authors thank all participating hospitals and clinicians for their
contribution to the study.
Funding
The study was supported by the Major Projects of the Guangzhou Medical
and Health Science and Technology (20151A031003) and the “Precision
Medical Research” 2016 Project of the National Key Research and
Development Plan (2016YFC0906302). These funding bodies played no direct
role in study design, data collection, analyses, and interpretation, manuscript
preparation and the decision to submit the article for publication.
Availability of data and materials
The datasets used and/or analyzed in the current study are available from
the corresponding author on reasonable request.
Authors’ contributions
Study Design: YPN. Data collection: WZ, XNL, HYL, XYK, QD, CJZ. Analysis and
interpretation of data: WZ, YTX. Drafting of the manuscript: WZ, YTX. Critical
revision of the manuscript: CHN, GSU. Approval of the final version for
publication: All the authors.
Ethics approval and consent to participate
Written informed consent was obtained from each subject. The research was
approved by the Ethics Committee of the Affiliated Brain Hospital of
Guangzhou Medical University.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests

Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1
The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou
Huiai Hospital), Guangzhou, China. 2Department of Psychiatry, University of
Melbourne, Melbourne, VIC, Australia. 3University Notre Dame Australia, Perth,
Australia. 4Division of Psychiatry, School of Medicine, University of Western
Australia, Perth, Australia. 5Unit of Psychiatry, Faculty of Health Sciences,
University of Macau, Macao SAR, China.
Received: 14 March 2018 Accepted: 5 July 2018

References
1. Cao XL, Wang SB, Zhong BL, Zhang L, Ungvari GS, Ng CH, Li L, Chiu HF, Lok
GK, Lu JP, et al. The prevalence of insomnia in the general population in
China: a meta-analysis. PLoS One. 2017;12(2):e0170772.
2. Liu X, Uchiyama M, Okawa M, Kurita H. Prevalence and correlates of
self-reported sleep problems among Chinese adolescents. Sleep. 2000;
23(1):27–34.
3. Morioka H, Itani O, Kaneita Y, Ikeda M, Kondo S, Yamamoto R, Osaki Y,
Kanda H, Higuchi S, Ohida T. Associations between sleep disturbance and

Zheng et al. BMC Psychiatry (2018) 18:232

4.
5.

6.

7.

8.

9.

10.

11.

12.

13.
14.

15.

16.

17.
18.

19.

20.

21.

22.
23.

24.
25.

alcohol drinking: a large-scale epidemiological study of adolescents in
Japan. Alcohol (Fayetteville, NY). 2013;47(8):619–28.
Hagg SA, Toren K, Lindberg E. Role of sleep disturbances in occupational
accidents among women. Scand J Work Environ Health. 2015;41(4):368–76.
Fullagar HH, Skorski S, Duffield R, Hammes D, Coutts AJ, Meyer T. Sleep and
athletic performance: the effects of sleep loss on exercise performance, and
physiological and cognitive responses to exercise. Sports medicine
(Auckland, NZ). 2015;45(2):161–86.
Scott JP, McNaughton LR, Polman RC. Effects of sleep deprivation and
exercise on cognitive, motor performance and mood. Physiol Behav. 2006;
87(2):396–408.
Ohayon MM, Lemoine P. A connection between insomnia and psychiatric
disorders in the French general population. L'Encephale. 2002;28(5 Pt 1):
420–8.
Rocha FL, Guerra HL, Lima-Costa MF. Prevalence of insomnia and associated
socio-demographic factors in a Brazilian community: the Bambui study.
Sleep Med. 2002;3(2):121–6.
Xiang YT, Ma X, Cai ZJ, Li SR, Xiang YQ, Guo HL, Hou YZ, Li ZB, Li ZJ, Tao YF,
et al. The prevalence of insomnia, its sociodemographic and clinical
correlates, and treatment in rural and urban regions of Beijing, China: a
general population-based survey. Sleep. 2008;31(12):1655–62.
Leger D, Poursain B. An international survey of insomnia: under-recognition
and under-treatment of a polysymptomatic condition. Curr Med Res Opin.
2005;21(11):1785–92.
Roth T. Insomnia: definition, prevalence, etiology, and consequences.
Journal of clinical sleep medicine : JCSM : official publication of the
American Academy of Sleep Medicine. 2007;3(5 Suppl):S7–10.
Ishigooka J, Suzuki M, Isawa S, Muraoka H, Murasaki M, Okawa M.
Epidemiological study on sleep habits and insomnia of new outpatients
visiting general hospitals in Japan. Psychiatry Clin Neurosci. 1999;53(4):515–22.
Ohayon MM, Hong SC. Prevalence of insomnia and associated factors in
South Korea. J Psychosom Res. 2002;53(1):593–600.
Camara-Lemarroy CR, Hoyos M, Ibarra-Yruegas BE, Diaz-Torres MA, De Leon
R. Affective symptoms and determinants of health-related quality of life in
Mexican people with epilepsy. Neurological sciences : official journal of the
Italian Neurological Society and of the Italian Society of Clinical
Neurophysiology. 2017;
Kim WH, Jung HY, Choi HY, Park CH, Kim ES, Lee SJ, Ko SH, Kim SY, Joa KL.
The associations between insomnia and health-related quality of life in
rehabilitation units at 1month after stroke. J Psychosom Res. 2017;96:10–4.
Gureje O, Makanjuola VA, Kola L. Insomnia and role impairment in the
community : results from the Nigerian survey of mental health and
wellbeing. Soc Psychiatry Psychiatr Epidemiol. 2007;42(6):495–501.
Ohayon MM, Partinen M. Insomnia and global sleep dissatisfaction in
Finland. J Sleep Res. 2002;11(4):339–46.
Institute of Medicine Committee on Sleep M, Research: The National
Academies Collection: Reports funded by National Institutes of Health. In:
Sleep Disorders and Sleep Deprivation: An Unmet Public Health Problem.
EDN Edited by Colten HR, Altevogt BM. Washington (DC): National
Academies Press (US) National Academy of Sciences.; 2006.
Ford ES, Wheaton AG, Cunningham TJ, Giles WH, Chapman DP, Croft JB.
Trends in outpatient visits for insomnia, sleep apnea, and prescriptions for
sleep medications among US adults: findings from the National Ambulatory
Medical Care survey 1999-2010. Sleep. 2014;37(8):1283–93.
Wang Z, Lian XY, Zhang XY. Study on cognitive status of insomnia in new
outpatients in traditional Chinese medicine clinic [in Chinese]. Chinese
Journal for Clinicians. 2016;44(5):107–9.
Linke M, Jankowski KS, Wichniak A, Jarema M, Wykes T. Effects of cognitive
remediation therapy versus other interventions on cognitive functioning in
schizophrenia inpatients. Neuropsychological rehabilitation. 2017:1–12.
Liu X, Zhou H: Sleep duration, insomnia and behavioral problems among
Chinese adolescents. Psychiatry Res 2002, 111(1):75–85.
Xiong N, Fritzsche K, Wei J, Hong X, Leonhart R, Zhao X, Zhang L, Zhu L,
Tian G, Nolte S, et al. Validation of patient health questionnaire (PHQ) for
major depression in Chinese outpatients with multiple somatic symptoms:
a multicenter cross-sectional study. J Affect Disord. 2015;174:636–43.
Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression
severity measure. J Gen Intern Med. 2001;16(9):606–13.
He XY, Li CB, Qian J, Cui HS, Wu WY. Reliability and validity of a generalized
anxiety disorder scale in general hospital outpatient. Shanghai Archives of
Psychiatry. 2010;22:200–3.

Page 7 of 7

26. Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing
generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):
1092–7.
27. Xiang YT, Buchanan RW, Ungvari GS, Chiu HF, Lai KY, Li YH, Si TM, Wang CY,
Lee EH, He YL, et al. Use of clozapine in older Asian patients with
schizophrenia between 2001 and 2009. PLoS One. 2013;8(6):e66154.
28. Kuok KCF, Li L, Xiang YT, Nogueira B, Ungvari GS, Ng CH, Chiu HFK, Tran L,
Meng LR. Quality of life and clinical correlates in older adults living in the
community and in nursing homes in Macao. Psychogeriatrics : the official
journal of the Japanese Psychogeriatric Society. 2017;17(3):194–9.
29. Dassori AM, Copeland LA, Zeber JE, Miller AL. Factors in second-generation
antipsychotic switching patterns in a national sample of older veterans with
schizophrenia. Psychiatric services (Washington, DC). 2011;62(1):47–53.
30. Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and
psychiatric disorders. An opportunity for prevention? Jama. 1989;262(11):
1479–84.
31. An FR, Qi YK, Zeng JY, Ding YM, Chiu HF, Ungvari GS, Newhouse R, Yu DS,
Lai KY, Xiang YT. The prevalence of insomnia, its demographic correlates,
and treatment in nurses working in Chinese psychiatric and general
hospitals. Perspectives in psychiatric care. 2016;52(2):88–94.
32. Jin LH. Analysis and treatment of insomnia. Chinese Health Care. 2008;8:381.
33. Su TP, Huang SR, Chou P. Prevalence and risk factors of insomnia in
community-dwelling Chinese elderly: a Taiwanese urban area survey. The
Australian and New Zealand journal of psychiatry. 2004;38(9):706–13.
34. Morphy H, Dunn KM, Lewis M, Boardman HF, Croft PR. Epidemiology of
insomnia: a longitudinal study in a UK population. Sleep. 2007;30(3):274–80.
35. Anderson KN, Bradley AJ. Sleep disturbance in mental health problems and
neurodegenerative disease. Nature and science of sleep. 2013;5:61–75.
36. Gu D, Sautter J, Pipkin R, Zeng Y. Sociodemographic and health correlates
of sleep quality and duration among very old Chinese. Sleep. 2010;33(5):
601–10.
37. Yang QZ, Bu YQ, Dong SY, Fan SS, Wang LX. A comparison of sleeping
problems in school-age children between rural and urban communities in
China. J Paediatr Child Health. 2009;45(7–8):414–8.
38. Ursin R, Bjorvatn B, Holsten F. Sleep duration, subjective sleep need, and
sleep habits of 40- to 45-year-olds in the Hordaland health study. Sleep.
2005;28(10):1260–9.
39. Bixler EO, Kales A, Soldatos CR, Kales JD, Healey S. Prevalence of sleep
disorders in the Los Angeles metropolitan area. Am J Psychiatry. 1979;
136(10):1257–62.
40. Hirotsu C, Bittencourt L, Garbuio S, Andersen ML, Tufik S. Sleep complaints
in the Brazilian population: impact of socioeconomic factors. Sleep science
(Sao Paulo, Brazil). 2014;7(3):135–42.

